Aims & Scope ::: Clinical Cancer Drugs

ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)


Volume 1, 2 Issues, 2014






Clinical Cancer Drugs

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Yuval Shaked
Department of Molecular Pharmacology, Rappaport Faculty of Medicine,Technion - Israel Institute of Technology
Haifa
Israel


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Aims & Scope

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.

Advertisement

Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science